Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 80379-31-3 | MDL No. : | MFCD29044869 |
Formula : | C12H12O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DDXHXXBEFRUFHF-UHFFFAOYSA-N |
M.W : | 220.22 | Pubchem ID : | 54689153 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 58.19 |
TPSA : | 55.76 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.15 cm/s |
Log Po/w (iLOGP) : | 2.5 |
Log Po/w (XLOGP3) : | 2.11 |
Log Po/w (WLOGP) : | 1.91 |
Log Po/w (MLOGP) : | 0.92 |
Log Po/w (SILICOS-IT) : | 1.98 |
Consensus Log Po/w : | 1.88 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.61 |
Solubility : | 0.535 mg/ml ; 0.00243 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.91 |
Solubility : | 0.27 mg/ml ; 0.00123 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.85 |
Solubility : | 0.31 mg/ml ; 0.00141 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.04 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | at 210℃; for 0.5 h; Inert atmosphere | The mixture of 2a (44 mg, 0.2 mmol) and Ph2O (400 mg) was heated to 210 °C under argon for 30 min. After cooling to the room temperature, the residue was purified on silica gel (PE/EtOAc, 30:1) to get the product as a colorless oil (25 mg, 84percent). 1H NMR (400 MHz, CDCl3): δ 7.26–7.22 (m, 1H), 7.14–7.12 (m, 1H), 7.06 (d, J=7.6 Hz, 2H), 4.41 (s, 2H), 3.62 (s, 2H); 13C NMR (100 MHz, CDCl3): δ 207.74, 154.65, 129.08, 128.58, 123.45, 121.63, 117.80, 73.08, 41.03 ppm. The date of the compound is identical with the described date of the reference.16 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With bis{rhodium[3,3'-(1,3-phenylene)bis(2,2-dimethylpropanoic acid)] In dichloromethane at 20℃; for 2 h; Inert atmosphere | General procedure: A solution of α-diazo-β-ketoester (0.5 mmol) in CH2Cl2 (5 mL) is added via syringe pump at a rate of 5–10 mL/h to a stirred solution of Rh2(esp)2 (2 mg, 0.5 mol percent) in anhydrous CH2Cl2 (5 mL) at room temperature under a nitrogen atmosphere. The reaction mixture was continued stirring for another hour upon the completion of addition. After evaporating all the volatiles, the residue was purified by flash column chromatography eluting with the mixture of petroleum ether and ethyl acetate (50:1). 4.3.1 Ethyl 3-hydroxy-2H-chromene-4-carboxylate (2a) (0032) Light yellow solid; isolated yield 90percent (100 mg). Rf 0.55 (PE/EtOAc, 10:1); mp 57.6–57.9 °C. 1H NMR (400 MHz, CDCl3) δ 12.97 (s, 1H), 7.78 (dd, J=7.9, 1.6 Hz, 1H), 7.07 (dt, J=7.9, 1.6 Hz, 1H), 6.98 (dt, J=7.9, 1.4 Hz, 1H), 6.91 (dd, J=7.9, 1.4 Hz, 1H), 4.65 (s, 2H), 4.43 (q, J=7.1 Hz, 2H), 1.44 (t, J=7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 171.01, 169.45, 151.40, 126.60, 125.85, 122.34, 120.12, 116.50, 97.20, 66.07, 61.65, 14.39 ppm; HRMS (ESI): m/z [M+H]+ calcd for C12H13O4 221.0808, found 221.0805. |
[ 1143-70-0 ]
3,8-Dihydroxy-6H-benzo[c]chromen-6-one
Similarity: 0.89
[ 6950-82-9 ]
2-(7-Hydroxy-2-oxo-2H-chromen-4-yl)acetic acid
Similarity: 0.88
[ 14003-96-4 ]
7-Hydroxy-4-methyl-2-oxo-2H-chromene-8-carbaldehyde
Similarity: 0.85
[ 37418-88-5 ]
4-Hydroxyisobenzofuran-1,3-dione
Similarity: 0.85
[ 1194700-73-6 ]
5-Hydroxy-4-methylisobenzofuran-1(3H)-one
Similarity: 0.81
[ 877997-98-3 ]
Phenyl 2-hydroxy-4,5-dimethoxybenzoate
Similarity: 0.90
[ 261767-10-6 ]
Ethyl 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate
Similarity: 0.90
[ 85614-43-3 ]
Methyl 5-allyl-2-hydroxy-3-methoxybenzoate
Similarity: 0.90
[ 1143-70-0 ]
3,8-Dihydroxy-6H-benzo[c]chromen-6-one
Similarity: 0.89
[ 6950-82-9 ]
2-(7-Hydroxy-2-oxo-2H-chromen-4-yl)acetic acid
Similarity: 0.88
[ 1143-70-0 ]
3,8-Dihydroxy-6H-benzo[c]chromen-6-one
Similarity: 0.89
[ 62935-72-2 ]
2-(7-Methoxy-2-oxo-2H-chromen-4-yl)acetic acid
Similarity: 0.88
[ 6950-82-9 ]
2-(7-Hydroxy-2-oxo-2H-chromen-4-yl)acetic acid
Similarity: 0.88
[ 14003-96-4 ]
7-Hydroxy-4-methyl-2-oxo-2H-chromene-8-carbaldehyde
Similarity: 0.85